Literature DB >> 1605004

Neuropeptides in human salivary (submandibular and parotid) glands.

C Hauser-Kronberger1, K Albegger, A Saria, G W Hacker.   

Abstract

The existence, distribution and density of various neuropeptides in human submandibular and parotid glands were investigated using immunocytochemistry and radioimmunoassay. Numerous nerve fibers containing vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM), or neuropeptide Y (NPY) and C-flanking peptide of NPY (CPON) immunoreactivities (ir) were found in close association to acini, ducts and blood vessels. Only few calcitonin gene-related peptide (CGRP)- and substance P (SP)-ir nerve fibers could be demonstrated, mainly localized around blood vessels and ducts. Galanin and the newly discovered peptides helospectin and pituitary adenylate cyclase activating peptide (PACAP) could not be detected in human salivary glands.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1605004     DOI: 10.1080/00016489.1992.11665430

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.

Authors:  A Jonas Ekstrand; Renhai Cao; Meit Bjorndahl; Susanne Nystrom; Ann-Cathrine Jonsson-Rylander; Hessameh Hassani; Bengt Hallberg; Margareta Nordlander; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

2.  Salivary beta-endorphin and substance P are not biomarkers of neuropathic chronic pain propensity.

Authors:  Thomas F Kallman; Bijar Ghafouri; Emmanuel Bäckryd
Journal:  Heliyon       Date:  2018-08-03

3.  The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?

Authors:  Karl Messlinger
Journal:  Cephalalgia       Date:  2021-10-04       Impact factor: 6.292

Review 4.  CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?

Authors:  Katharina Kamm
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.